Experimental chewing gum reduces Omicron in saliva: study
The gum contains copies of the ACE2 protein found on cell surfaces that the coronavirus uses to infect them, say US researchers
An experimental chewing gum that “traps” SARS-CoV-2 particles in saliva holds promise for curbing transmission of new variants of the virus, according to new data, as US researchers prepare to launch the first human trial.
The gum contains copies of the ACE2 protein found on cell surfaces, which the coronavirus uses to break into cells and infect them.
